DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform

The article describes a biotech collaboration in which Genentech will take over further global clinical development and commercialization for DualityBio’s DUPAC ADC payload platform. The deal leverages DualityBio’s proprietary technology and its early global clinical development capabilities, with GENENTECH progressing the program through later stages.